GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (BUE:BMY) » Definitions » Shiller PE Ratio

Bristol-Myers Squibb Co (BUE:BMY) Shiller PE Ratio : 37.35 (As of May. 06, 2024)


View and export this data going back to . Start your Free Trial

What is Bristol-Myers Squibb Co Shiller PE Ratio?

As of today (2024-05-06), Bristol-Myers Squibb Co's current share price is ARS16450.50. Bristol-Myers Squibb Co's E10 for the quarter that ended in Mar. 2024 was ARS440.40. Bristol-Myers Squibb Co's Shiller PE Ratio for today is 37.35.

The historical rank and industry rank for Bristol-Myers Squibb Co's Shiller PE Ratio or its related term are showing as below:

BUE:BMY' s Shiller PE Ratio Range Over the Past 10 Years
Min: 18.28   Med: 29.08   Max: 54.46
Current: 35.47

During the past years, Bristol-Myers Squibb Co's highest Shiller PE Ratio was 54.46. The lowest was 18.28. And the median was 29.08.

BUE:BMY's Shiller PE Ratio is ranked worse than
68.17% of 531 companies
in the Drug Manufacturers industry
Industry Median: 25.32 vs BUE:BMY: 35.47

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Bristol-Myers Squibb Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ARS-4,962.325. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ARS440.40 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bristol-Myers Squibb Co Shiller PE Ratio Historical Data

The historical data trend for Bristol-Myers Squibb Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Shiller PE Ratio Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.35 48.49 43.84 43.29 26.98

Bristol-Myers Squibb Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.63 35.04 30.89 26.98 43.73

Competitive Comparison of Bristol-Myers Squibb Co's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bristol-Myers Squibb Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Shiller PE Ratio falls into.



Bristol-Myers Squibb Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Bristol-Myers Squibb Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=16450.50/440.4
=37.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bristol-Myers Squibb Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Bristol-Myers Squibb Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-4962.325/129.4194*129.4194
=-4,962.325

Current CPI (Mar. 2024) = 129.4194.

Bristol-Myers Squibb Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 1.625 100.560 2.091
201409 3.620 100.428 4.665
201412 0.086 99.070 0.112
201503 6.262 99.621 8.135
201506 -0.727 100.684 -0.934
201509 3.949 100.392 5.091
201512 -1.035 99.792 -1.342
201603 10.369 100.470 13.357
201606 9.646 101.688 12.277
201609 10.740 101.861 13.646
201612 8.402 101.863 10.675
201703 14.492 102.862 18.234
201706 9.233 103.349 11.562
201709 8.937 104.136 11.107
201712 -26.924 104.011 -33.501
201803 18.336 105.290 22.538
201806 5.736 106.317 6.982
201809 42.687 106.507 51.870
201812 27.525 105.998 33.607
201903 40.654 107.251 49.057
201906 38.871 108.070 46.550
201909 46.419 108.329 55.456
201912 -32.875 108.420 -39.242
202003 -21.104 108.902 -25.080
202006 -2.738 108.767 -3.258
202009 60.877 109.815 71.745
202012 -362.141 109.897 -426.473
202103 80.171 111.754 92.844
202106 44.523 114.631 50.267
202109 67.468 115.734 75.446
202112 108.059 117.630 118.890
202203 63.350 121.301 67.590
202206 79.418 125.017 82.215
202209 104.212 125.227 107.701
202212 159.267 125.222 164.606
202303 211.379 127.348 214.818
202306 237.600 128.729 238.875
202309 325.454 129.860 324.351
202312 314.070 129.419 314.070
202403 -4,962.325 129.419 -4,962.325

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bristol-Myers Squibb Co  (BUE:BMY) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Bristol-Myers Squibb Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bristol-Myers Squibb Co (BUE:BMY) Business Description

Address
430 East 29th Street, 14th Floor, New York, NY, USA, 10016
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.